neuromuscular agents

Preferred Label : neuromuscular agents;

MeSH definition : Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS.;

MeSH synonym : agents, neuromuscular;

MeSH hyponym : skeletal muscle relaxants; Muscle Relaxants, Skeletal; Relaxants, Skeletal Muscle;

Related MeSH term : neuromuscular effect; Effect, Neuromuscular; Neuromuscular Effects; Effects, Neuromuscular;

MeSH annotation : general or unspecified; prefer specifics; note entry term NEUROMUSCULAR EFFECT: use only for the neuromuscular effect of a chemical substance;

Wikipedia link : https://en.wikipedia.org/wiki/Neuromuscular agents;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D009465;

UMLS CUI

C0027865;

ATC code(s)
- botulinum toxin [ATC Code]
- fazadinium bromide [ATC Code]
- hexafluronium [ATC Code]
- muscle relaxants [ATC Code]
- muscle relaxants, peripherally acting agents [ATC Code]
- other muscle relaxants, peripherally acting agents [ATC Code]
- pridinol [ATC Code]
- thiocolchicoside [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Skeletal muscle relaxants [ICD-11 Extension code]
Manual NTBT mappings (CISMeF)
- Muscle relaxants [Bloc CIM-11]
Record concept(s)
- neuromuscular agents [MeSH concept]
- neuromuscular effect [MeSH concept]
- skeletal muscle relaxants [MeSH concept]
See also (suggested by CISMeF)
- rheumatology [CISMeF Metaterm]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- Amifampridine [MeSH Descriptor]
- Risdiplam [MeSH Supplementary Concept]
- botulinum toxin type F [MeSH Supplementary Concept]
- botulinum toxins, type A [MeSH Descriptor]
- bucloxic acid [MeSH Supplementary Concept]
- incobotulinumtoxinA [MeSH Supplementary Concept]
- metaxalone [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Skeletal muscle relaxants [ICD-11 Extension code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients